The Clinical Research and Patient Care Core programs for this center application are based in the East Bay at Children's Hospital-Oakland, Alta Bates Hospital-Berkeley and Highland General Hospital-Oakland and in the West Bay at San Francisco General Hospital/University of California, San Francisco. The large patient population enrolled in these cooperative clinical programs provides us with an ideal resource to conduct the clinical and basic research projects and plan new research projects. The success of these interactions is reflected in our publications related to basic and clinical research on sickle cell disease, (listed in the summary progress report), in our participation in national efforts to establish treatment guidelines for patients with sickle cell disease and in our contributions to implement newborn screening for sickle cell disease. This application describes a number of new clinical research projects: 1) Acute Chest Syndrome, 2) Pediatric Hydroxyurea Trial, 3) Bone Marrow Transplantation, 4) Gamma Interferon- Pneumococcal Vaccine Trial, 5) Longitudinal studies of children up to three years of age and 6) the efficacy of Ketorolac to control pain in patients with vaso-occlusive crises. In addition to the above projects the core will provide necessary blood samples for many basic research programs. In summary, the strength of the clinical core in our Center application will enable us to complete successfully the proposed clinical research projects and participate in the basic research projects.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL020985-19
Application #
5213303
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Goodman, Jessica; Hassell, Kathryn; Irwin, David et al. (2014) The splenic syndrome in individuals with sickle cell trait. High Alt Med Biol 15:468-71
James, Ellen Butensky; Vreman, Hendrik J; Wong, Ronald J et al. (2010) Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy. Pediatr Hematol Oncol 27:112-21
Jenkins, Zandra A; Hagar, Ward; Bowlus, Christopher L et al. (2007) Iron homeostasis during transfusional iron overload in beta-thalassemia and sickle cell disease: changes in iron regulatory protein, hepcidin, and ferritin expression. Pediatr Hematol Oncol 24:237-43
Styles, Lori A; Abboud, Miguel; Larkin, Sandra et al. (2007) Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol 136:343-4
Kuypers, Frans A; Larkin, Sandra K; Emeis, Jef J et al. (2007) Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb Haemost 97:478-86
Neumayr, Lynne D; Aguilar, Christine; Earles, Ann N et al. (2006) Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am 88:2573-82
Wilson, Leslie S; Moskowitz, Judith Tedlie; Acree, Michael et al. (2005) The economic burden of home care for children with HIV and other chronic illnesses. Am J Public Health 95:1445-52
Vichinsky, Elliott; Butensky, Ellen; Fung, Ellen et al. (2005) Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol 80:70-4
Pakbaz, Zahra; Fischer, Roland; Treadwell, Marsha et al. (2005) A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia. Ann N Y Acad Sci 1054:486-91
Banerjee, Tinku; Kuypers, Frans A (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 124:391-402

Showing the most recent 10 out of 207 publications